VIRFLOX-OZ I.U. SUSPENSION

Description

VIRFLOX-OZ I.U. SUSPENSION: Effective Treatment for Intrauterine Diseases

VIRFLOX-OZ I.U. SUSPENSION combines Ofloxacin L.P. (50 mg) and Ornidazole I.P. (125 mg), offering potent antimicrobial action against aerobic and anaerobic bacteria, as well as protozoa. Ofloxacin exhibits bactericidal activity against a wide range of aerobic bacteria, while Ornidazole demonstrates antimicrobial efficacy against anaerobic bacteria and protozoa. Indicated for intrauterine diseases such as metritis, cervicitis, and post-partum septic metritis, VIRFLOX-OZ effectively treats inflammatory conditions of the uterus and vagina.

Advantages:

1. Broad Spectrum Action: Ofloxacin targets aerobic bacteria, while Ornidazole tackles anaerobic bacteria and protozoa, ensuring comprehensive antimicrobial coverage.
2. Potent Activity: With potent bactericidal and antimicrobial properties, VIRFLOX-OZ provides effective treatment for a range of intrauterine diseases.

Composition and Role of Each Ingredient:

• Ofloxacin L.P. (50 mg): Exhibits potent bactericidal activity against aerobic bacteria, including both gram-negative and gram-positive strains.
• Ornidazole I.P. (125 mg): Demonstrates strong antimicrobial activity against anaerobic bacteria and protozoa, aiding in the resolution of intrauterine infections.

Indications:

• Effective for treating intrauterine diseases such as metritis, cervicitis, post-partum septic metritis, endometritis, pyometra, and vaginitis.

Dosage:

• Administer 60 ml via the intrauterine (I.U.) route in cows, buffaloes, and mares, continuing treatment for 3 to 5 days or as directed by a veterinarian.

VIRFLOX-OZ I.U. SUSPENSION is available in a 60 ml pack, ensuring convenient and effective treatment options for intrauterine diseases in animals.